Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery

Autor: Guntram Schernthaner, S. Kriwanek, Renate Koppensteiner, K. Krzyzanowska, H.‐P. Kopp
Rok vydání: 2006
Předmět:
Zdroj: European Journal of Clinical Investigation. 36:395-401
ISSN: 1365-2362
0014-2972
DOI: 10.1111/j.1365-2362.2006.01649.x
Popis: Background Morbid obesity is associated with increased cardiovascular morbidity and mortality. Recent studies suggest that soluble CD40 Ligand (sCD40L) may play a pathogenetic role in atherothrombotic complications in cardiovascular disease as well as in inflammation and thrombosis. As morbid obesity is closely associated with chronic inflammation and insulin resistance (IR), it was of interest to study sCD40L in patients with morbid obesity before and after massive weight loss induced by bariatric surgery. Patients and methods A total of 34 patients (mean age 40 ± 12 years) with morbid obesity were studied before and 27·2 months after bariatric surgery. High sensitivity assays were used to measure concentrations of fasting sCD40L, monocyte-chemoattractant-protein-1 (MCP-1) and high-sensitive C-reactive protein (hsCRP). To investigate the associations of concentration changes of the parameters studied, differences between pre- and post-operative data were assessed and tested by univariate and multivariate linear regression analysis. Results After a mean weight loss of 33·1 ± 18·4 kg, circulating sCD40L decreased significantly from (3·7 ± 1·5) ng mL−1 to (2·2 ± 0·7) ng mL−1, (P
Databáze: OpenAIRE